Physical inactivity, Type 2 diabetes linked in new research
NEW YORK — Physical inactivity may play a key role in the development of Type 2 diabetes, according to new research.
John Thyfault, an assistant professor at the University of Missouri’s departments of nutrition and exercise physiology and internal medicine, studied the relationship between low levels of physical activity and elevated levels of postprandial glucose, which refers to the spikes in blood sugar that occur after a meal. PPG, which has been associated with increased incidences of cardiovascular disease and death, also is a risk factor for the development of Type 2 diabetes. What Thyfault found while monitoring activity levels and diets of healthy and moderately active young adults, was that those people that reduced their physical activity by about half for three days saw their PPG responses to meals double.
"We now have evidence that physical activity is an important part of the daily maintenance of glucose levels," Thyfault said. "Even in the short term, reducing daily activity and ceasing regular exercise causes acute changes in the body associated with diabetes that can occur before weight gain and the development of obesity.
"This study shows that physical activity directly impacts health issues that are preventable," he concluded.
The study is being published in Medicine & Science in Sports & Exercise.
New SoloHealth kiosks to use latest Intel technology
NEW YORK — The next generation of health kiosks made by SoloHealth will use the latest technologies from Intel, the company said.
The SoloHealth Station — which measures blood pressure, vision, weight and body mass index — will use an Intel Core i5 processor-based computer and deliver an interactive, secure and networked experience for consumers. It also will allow easy repairs and adjustments that can be made from one centralized computer.
SoloHealth developed the SoloHealth Station, currently in a test program with an unspecified nationwide retailer, under a partnership with Intel.
The company, which will be at the National Association of Chain Drug Stores’ Pharmacy & Technology Conference in Boston starting Saturday, said it also was in talks with drug, mass merchandise and grocery chains around the country, as well as healthcare providers and businesses, to deploy the SoloHealth Station at more locations.
Intel recently released a case study on the kiosks, available here.
Novo Nordisk to build new corporate HQ
BAGSVÆRD, Denmark — Novo Nordisk is investing 1 billion Danish kroner ($193.9 million) into two new office buildings in Bagsværd, Denmark.
The drug maker said the new premises will house Novo Nordisk’s top management, 1,100 administrative employees and a number of shared facilities.
“Although Novo Nordisk is primarily set to grow outside of Denmark in the coming years, we are looking forward to consolidating the administrative functions in Bagsværd, where we have been present since the 1950s,” Novo Nordisk president and CEO Lars Rebien Sørensen said. “The new buildings will give our employees the best conditions for interacting across functional divides and with our colleagues abroad.”